Skip to content

Mental Imagery and Targeted Memory Reactivation in Insomnia

Mental Imagery and Targeted Memory Reactivation in Insomnia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06335784
Enrollment
120
Registered
2024-03-28
Start date
2024-04-22
Completion date
2027-08-31
Last updated
2026-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia Disorder

Keywords

Insomnia, Odors, Imagery, TMR

Brief summary

In this clinical trial, the investigators test whether mental Imagery Rescripting (IR), a technique where the individual is instructed to transform a negative memory or image into a positive one, and olfactory Targeted Memory Reactivation (TMR), a technique used to strengthen memories, can reduce hyperarousal and insomnia severity in patients with Insomnia Disorder (ID). Patients with ID will be randomized into four groups: in the first group (SH group), patients will have 4 weekly sessions (1 session/week) of a minimal intervention for insomnia (sleep hygiene information) in the presence of an odorless diffuser, which will be also used during the night. In the second group (IR group), patients will use IR during wakefulness to induce a state of relaxation and positive emotionality. More specifically, during 4 weekly sessions of IR, patients will imagine a negative scenario related to their pre-sleep images or current concerns (e.g., social interactions, self-image, sleep problem, nightmares) and transform it into a positive script. They will then perform IR every day for 4 weeks at home in the presence of an odorless diffuser, which will be also used during the night. In the third group, patients will undergo the same 4 weekly IR sessions and an odor will be paired to the positive imagery and will be diffused during the night (TMR group). Patients from this group will also perform IR every day for 4 weeks at home. Finally, the fourth group (OA group) will receive 4 weekly sessions of sleep hygiene instructions in the presence of an odor, which will be also used during the night. Clinical evaluation of insomnia severity before and after the intervention will take place using the Insomnia Severity Index (ISI, primary outcome measure). At the end of these interventions, patients with persistent symptoms will benefit from an alternative experimental treatment ("rocking bed") in which they will be cradled for one night. The investigators hypothesize that patients treated with IR will have significantly reduced insomnia severity compared to participants who received a minimal intervention. They also hypothesize that patients of the TMR group, will have more reduced ID severity compared to participants performing IR and with an odorless diffuser, therefore without an association (IR group). Finally, they hypothesize that one night of sleeping in a rocking bed will improve objective measures of sleep in ID compared to a stationary condition.

Interventions

BEHAVIORALImagery Rescripting (IR)

Imagery rescripting (IR) is a technique where the individual is instructed to imagine a negative memory or image as vividly as possible, and to change it in a direction that he/she desires. IR seems particularly efficient because it is based on the experienced emotions during perceptual information processing, thereby eliciting stronger emotional responses than verbal processing.

BEHAVIORALImagery Rescripting (IR) and Targeted Memory Reactivation (TMR) during sleep

Targeted Memory Reactivation (TMR) is a technique used to strengthen a memory trace during sleep. TMR is used to modify memory formation through the application of cues during sleep. In this TMR protocol, an olfactory cue is associated with the imagery rescripting (IR) during the day, and then administered during sleep. In that way, the replay of the associated memory and its corresponding neural representation in memory networks are artificially promoted, a procedure which usually strengthens memory consolidation. Previous studies have shown that TMR in sleep reduces emotional arousal, making it a promising technique for insomnia.

BEHAVIORALSleep Hygiene

Sleep hygiene education includes modifications in the behavior (e.g., exercise, coffee, alcohol intake) and environment (e.g., light, noise, temperature conditions) that offer to the individual the foundation for healthy sleep. Sleep hygiene is an important component in treating ID, but insufficient and less effective than CBT-I when offered alone.

BEHAVIORALSleep Hygiene + Odor

Sleep hygiene instructions will be applied in the presence of an odor, which will be also used during the night.

OTHER"Rocking bed" if patients still have insomnia complaints (ISI >10) after the 4 weeks of the intervention

Rocking stimulation boosts brain oscillations in deep sleep (i.e., sleep spindles and slow oscillations) into a rhythmic appearance supporting a neurophysiological mechanism whereby continuous rocking entrains endogenous thalamo-cortical sleep oscillations. The beneficial effects of rocking strengthening the continuity of sleep might have clinical applications and it will be of interest to evaluate if such non-pharmacological could improve sleep and reduce such features of hyperarousal in ID patients.

Sponsors

University Hospital, Geneva
Lead SponsorOTHER
University of Geneva, Switzerland
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 45 years * Insomnia disorder according to the International Classification of Diseases 3 (ICSD-3) * ISI \> 10 * PSQI \> 5 * No other current treatment for Insomnia

Exclusion criteria

* patients with another psychiatric disorder requiring acute treatment according to DSM-5 * patients with medical (e.g. neurological disorders) or other disorders explaining the predominant complaint of insomnia (e.g., sleep apneas with ODI\>15/h, restless legs syndrome, periodic limb movements with PLM\>15, chronic pain) * patients with significant substance use/withdrawal * patients with heavy smoking * known pregnancy * patients suffering from anosmia, olfactory related issues and respiratory pathology

Design outcomes

Primary

MeasureTime frameDescription
Insomnia Severity Index (ISI)Baseline, 5 Weeks and 3 MonthsStandardized questionnaire that measures ID severity, the score ranges from 0-28, zero indicating no symptom severity and 28 indicating the higher symptom severity.

Secondary

MeasureTime frameDescription
Pittsburgh sleep quality index (PSQI)Baseline, 5 Weeks and 3 MonthsValidated self-report scale to assess the quality of sleep, the score ranges from 0-21, zero indicating no symptom severity and 21 indicating the higher symptom severity.
Total Sleep Time (TST)Baseline and 5 WeeksTime from sleep onset to sleep offset. This outcome is measured both subjectively and objectively.
Wake After Sleep Onset (WASO)Baseline and 5 WeeksNumber of awakenings during the night. This outcome is measured both subjectively and objectively.
Beck Depression Inventory II (BDI-II)Baseline, 5 Weeks and 3 MonthsValidated self-report scale to assess depressive symptoms, the score ranges from 0-63, zero indicating no symptom severity and 63 indicating the higher symptom severity.
State Trait Anxiety Inventory (STAI)Baseline, 5 Weeks and 3 MonthsValidated self-report scale to assess anxiety, the score ranges from 20-80, 20 indicating no symptom severity and 80 indicating the higher symptom severity.
Sleep efficiency (SE)Baseline and 5 WeeksRatio between total time spent in bed and total sleep time. This outcome is measured both subjectively and objectively.
Micro-arousalsBaseline and 5 WeeksObjective measure of micro-awakenings during the night.

Countries

Switzerland

Contacts

CONTACTLampros Perogamvros
Lampros.Perogamvros@hcuge.ch+41223729946
CONTACTKevin Mammeri
Kevin.Mammeri@unige.ch+33627694534

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026